158
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Formulation development and evaluation of nifedipine as pylorospasm inhibitor

, , , , , & show all
Pages 1171-1184 | Received 18 Nov 2017, Accepted 31 Jan 2018, Published online: 21 Feb 2018

References

  • Sultana S, Bhavna, Iqbal Z, et al. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm. J Microencapsul. 2008;26: 1–9.
  • James AN, Ryan AN, Parkman HP. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2003;285:G291–G297.
  • Lacy BE, Crowell MD, Schettler-Duncan A, et al. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care.2004;27:2341–2347.
  • Lockwood GR. Pyloric spasm and pyloric stenosis. Diseases of the stomach: including dietetic and medicinal treatment. Philadelphia: Lea & Febiger; 1913. p. 347–356.
  • Jaffin BW, Kaye MD. The prognosis of gastric outlet obstruction. Ann Surg. 1985;201:176–179.
  • Harold E. Pyloric stenosis complicating duodenal ulceration. World J Surg. 1987;11:315.
  • Fichardt T. The diagnosis of gastric disorder. S.A. Med J. 1941;15:63–68.
  • Rosemurgy AS, Donn N, Paul H, et al. Gastroesophageal reflux disease. Surg Clin North Am. 2011;91:1015–1029.
  • Rayner CK, Horowitz M. New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol. 2005;2:454–462.
  • Camilleri M, Parkman HP, Shafi MA, et al. American college of gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2003;108:18–37.
  • Chuah SK, Wu KL, Hu TH. Endoscope-guided pneumatic dilation for treatment of esophageal achalasia. World J Gastroenterol. 2010;16:411–417.
  • Sultana S, Talegaonkar S, Bhatnagar A, et al. Optimization of nifedipine loaded gastroretentive microcapsules for biliary colic. Asian J Pharm. 2012;6:295–306.
  • Taylor AT. High-altitude illnesses: physiology, risk factors, prevention, and treatment. Rambam Maimonides Med J. 2011;2:1–18.
  • Pund S, Joshi A, Vasu K, et al. Gastroretentive delivery of rifampicin: in vitro mucoadhesion and in vivo gamma scintigraphy. Int J Pharm. 2011;411:106–112.
  • Lim ST, Martina GP, Berry DJ, et al. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release. 2000;66:281–292.
  • Zhang Y, Wei W, Lv P, et al. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur J Pharm Biopharm. 2011;77:11–19.
  • Arora S, Budhiraja RD. Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion. J Adv Pharm Technol Res. 2012;3:68–74.
  • Sathali AAH, Varun J. Formulation, development and in vitro evaluation of candesartan cilexetil mucoadhesive microbeads. Int J Curr Pharm Res. 2012;4:109–118.
  • Vaezi MF, John E, Pandolfino JE, et al. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol 2013;108:1238–1249.
  • Davis MP. Drug management of visceral pain: concepts from basic research. Pain Res Treat. 2012;2012:265605.
  • Marger F, Gelot A, Alloui A, et al. T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome. Proc Natl Acad Sci USA. 2011;108:11268–11273.
  • Jiang W, Kirkup AJ, Grundy D. Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia. J Physiol. 2011;589:3867–3882.
  • Yoshimoto M, Sasaki M, Naraki N, et al. Regulation of gastric motility at simulated high altitude in conscious rats. J Appl Physiol. 2004;97:599–604.
  • Joshi BP. High altitude hospitality. J Tourism Hospitality. 2017;7:62–82.
  • Haruta S, Kawai K, Jinnouchi S, et al. Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy. J Pharmaceutical Sci. 2001;90:464–473.
  • Szarka LA, Camilleri M. Methods for measurement of gastric motility. Am J Physiol Gastrointest Liver Physiol. 2009;296:G461–G475.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.